Skip to main content

Table 1 Breast cancer study subjects and hormone status.

From: Role of human HGFIN/nmbin breast cancer

Subject (patient no. or tissues)

Age range (years)

ER

PR

HER2 (IHC)

In situdensities (range)

1–3

65–73

-

-

-

<0.2–1.2

19–28

54–60

    

29–35

36–60

    

4–7

55–60

+

+

1+

1–1.5

8–10

60–64

    

11–18

70–82

+

+

-

0.5–1

36–50

56–65

    

Benign tissues

35–60

Not performed

Not performed

Not performed

10

  1. The demographics of patients and their hormonal status are given. The patients are grouped based on hormonal status and are coded with assigned numbers. All patients were diagnosed with infiltrating ductal carcinomas. ER, estrogen receptor; PR, progesterone receptor; HER2, c-erbB-2; IHC, immunohistochemistry.